. Author manuscript; available in PMC: 2011 Mar 1.

Published in final edited form as: J Clin Exp Neuropsychol. 2009 May 29;32(3):231–238. doi: 10.1080/13803390902926184

Table 3.

RBANS Indexes in the HD and other clinical samples

RBANS score	HD	AD	PDD	PDND	MS impaired	MS intact
Immediate Memory	70.7 (20.7)	63.9 (13.1)^*	66.7 (12.0)	81.6 (17.5)^*	79.1 (14.3)	96.4 (14.7)^**
Visuospatial/Constructional	78.1 (17.6)	82.6 (16.8)	70.9 (18.3)	92.5 (16.9)^**	101.3 (21.7)^**	102.7 (15.7)^**
Language	82.3 (13.2)	81.1 (12.8)	86.4 (10.3)	91.6 (8.1)^**	90.6 (11.7)	94.0 (10.9)^**
Attention	67.7 (17.7)	77.9 (18.5)^**	69.3 (13.6)	91.0 (15.9)^**	87.8 (17.9)^**	91.7 (15.5)^**
Delayed Memory	74.5 (2.3)	54.7 (15.8)^**	71.1 (16.3)	83.4 (16.4)	77.6 (22.8)	95.5 (14.9)^**
Total Scale	69.7 (17.2)	64.5 (13.1)^*	65.9 (11.0)	84.4 (13.6)^**	83.1 (19.2)^*	94.5 (13.4)^**

Note. Means and standard deviations (in parentheses) are presented. HD = Huntington's disease sample from the current study. AD = Alzheimer's disease from Duff et al. (2008). PDD and PDND = Parkinson's disease with dementia and Parkinson's disease no dementia (respectively) from Beatty et al. (2003). MS = Multiple sclerosis from Beatty et al. (2004). All comparisons are with HD group.

= p<0.05,

^**

= p<0.01.

Individual subtest differences can either be obtained from the first author or from the original articles.